Newsroom
Sorted by: Latest
-
Aelis Farma Announces Its 2026 Financial Calendar
BORDEAUX, France--(BUSINESS WIRE)--Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS, PEA-PME eligible), a clinical-stage biopharmaceutical company specializing in the development of treatments for brain and peripheral diseases involving the CB1 receptor, today announces its indicative financial calendar for the financial year 2026. Event Date of release* 2025 Annual Results Monday, March 30, 2026 Annual General Meeting Wednesday, June 3, 2026 2026 Half-Year Results Tuesd...
-
PROLLENIUM® Names Erick Brenner as Chief Executive Officer
RICHMOND HILL, Ontario--(BUSINESS WIRE)--PROLLENIUM® Medical Technologies, a privately held medical aesthetics company, has appointed Erick Brenner as Chief Executive Officer, effective immediately. Brenner succeeds Walter Geiger, who has served as Interim CEO since April 2025, and will return to his role as Operating Partner at ARCHIMED, PROLLENIUM®’s majority shareholder. Brenner most recently served as President of Galderma U.S., where he oversaw a $1.8 billion portfolio across injectable ae...
-
Primeˣ 260 and Slimˣ 260 Set a New Standard for Long-Range, Ultra-Precise Motion Capture with 26 MP Resolution and ±0.050 mm 3D Accuracy
CORVALLIS, Ore.--(BUSINESS WIRE)--OptiTrack, a worldwide leader in 3D optical tracking systems, today announced the 260 X-Series camera family, built to deliver OptiTrack’s highest-accuracy tracking in demanding, large-volume environments. Primeˣ and Slimˣ 260 brings together ±0.050 mm 3D accuracy (50 microns) and a 26 Megapixel sensor to deliver exceptionally stable tracking across massive capture spaces, up to 40m passive range and 91m active tracking range. Higher pixel density improves trac...
-
Aelis Farma annonce son calendrier financier pour l’exercice 2026
BORDEAUX, France--(BUSINESS WIRE)--Regulatory News : Aelis Farma (ISIN : FR0014007ZB4 – Mnémonique : AELIS, éligible PEA-PME), société biopharmaceutique au stade clinique spécialisée dans le développement de traitements des maladies cérébrales et périphériques impliquant le récepteur CB1, annonce aujourd’hui son calendrier financier indicatif pour l’exercice 2026. Évènement Date de publication* Résultats annuels 2025 Le lundi 30 mars 2026 Assemblée générale annuelle Le mercredi 3 juin 202...
-
JACQUET METALS SA : Déclaration au titre de l'article 223-16 du Règlement Général de l'Autorité des Marchés Financiers
SAINT-PRIEST, France--(BUSINESS WIRE)--Regulatory News: JACQUET METALS SA (Paris:JCQ) : Date Nombre d'actions composant le capital Nombre de droits de vote théoriques 31 décembre 2025 21 531 967 31 280 810 Le nombre total des droits de vote exerçables attachés à ces 21 531 967 actions s’élève à 30 048 679 droits de vote en tenant compte des 1 232 131 actions autodétenues par JACQUET METALS SA et privées de droits de vote en vertu des articles L.225-111 et L.225-210 du Code de commerce....
-
JACQUET METALS SA: Statement in Compliance With the Article 223-16 of the General Regulation of the Financial Markets Authority (AMF - Autorité des Marchés Financiers)
SAINT-PRIEST, France--(BUSINESS WIRE)--Regulatory News: JACQUET METALS SA (Paris:JCQ): Date Total number of shares Number of theoretical voting rights December 31, 2025 21 531 967 31 280 810 The total number of exercisable voting rights attached to these 21 531 967 shares is 30 048 679, taking into account the 1 232 131 treasury shares held by JACQUET METALS SA and stripped of voting rights under Articles L.225-111 and L.225-210 of the French Commercial Code....
-
JACQUET METALS : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC ODDO BHF
SAINT-PRIEST, France--(BUSINESS WIRE)--Regulatory News: Au titre du contrat de liquidité confié par la société JACQUET METALS (Paris:JCQ) à ODDO BHF, à la date du 31 décembre 2025, les moyens suivants figuraient au compte de liquidité : 20 978 titres 400 368,61 Euros en espèces Il est rappelé qu’à la date de signature du contrat, les ressources suivantes figuraient au compte de liquidité : 40 139 titres 377 936,24 Euros en espèces Sur la période du 1er juillet 2025 au 31 décembre 2025 ont été e...
-
75% of Visitors Will Switch to a Competitor When a Website Feels Unsafe, Liferay Survey Finds
LOS ANGELES--(BUSINESS WIRE)--Everyday browsing is full of risk, and even minor inconsistencies can derail trust. Liferay, a leading provider of Digital Experience Platforms (DXPs), reveals in its latest research that 75% of users will abandon a website that feels unsafe or behaves oddly, often switching to a competitor to complete the same task. The 2026 Liferay Broken Trust Report, conducted in December 2025, surveyed 1,000 U.S. adults aged 18 and older across regions and demographics via the...
-
Sally Beauty Holdings Announces Conference Call and Webcast to Discuss First Quarter Financial Results on February 9, 2026
DENTON, Texas--(BUSINESS WIRE)--Sally Beauty Holdings, Inc. (NYSE:SBH) (the “Company”), the leader in professional hair color, announced today that it will host a conference call and webcast on February 9, 2026, at 7:30 a.m. Central Time, to discuss its first quarter financial results. A copy of the press release announcing the first quarter financial results is expected to be made available on February 9, 2026, before the U.S. financial markets open on the Company's website sallybeautyholdings...
-
Citizens Financial Group Announces Redemption of Subordinated Notes
PROVIDENCE, R.I.--(BUSINESS WIRE)--Citizens Financial Group, Inc. (NYSE: CFG) today announced the redemption on February 11, 2026, of all of its outstanding 4.300% Fixed Rate Reset Subordinated Notes due February 11, 2031 (CUSIP No. 174610BA2), all of its outstanding 3.750% Fixed Rate Reset Subordinated Notes due February 11, 2031 (CUSIP No. 174610AY1), and all of its outstanding 4.350% Fixed Rate Reset Subordinated Notes due February 11, 2031 (CUSIP No. 174610BC8) (collectively, the “Notes”)....